Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.

par Matteo Surdo, Emanuela Balestra, Patrizia Saccomandi, Fabiola Di Santo, Marco Montano, Domenico Di Carlo, Loredana Sarmati, Stefano Aquaro, Massimo Andreoni, Valentina Svicher, Carlo Federico Perno, Francesca Ceccherini-Silberstein
Publié 2013

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol.

par Alex Durand Nka, Georges Teto, Maria Mercedes Santoro, Valantine Ngum Ndze, Désiré Takou, Beatrice Dambaya, Ezechiel Ngoufack Jagni Semengue, Lavinia Fabeni, Carlo-Federico Perno, Vittorio Colizzi, Francesca Ceccherini-Silberstein, Joseph Fokam
Publié 2021

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.

par Valentina Svicher, Valeria Cento, Gabriella Rozera, Isabella Abbate, Maria Mercedes Santoro, Daniele Armenia, Lavinia Fabeni, Alessandro Bruselles, Alessandra Latini, Guido Palamara, Valeria Micheli, Giuliano Rizzardini, Caterina Gori, Federica Forbici, Giuseppe Ippolito, Massimo Andreoni, Andrea Antinori, Francesca Ceccherini-Silberstein, Maria Rosaria Capobianchi, Carlo Federico Perno
Publié 2013

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.

par Daniele Armenia, Cathia Soulie, Domenico Di Carlo, Lavinia Fabeni, Caterina Gori, Federica Forbici, Valentina Svicher, Ada Bertoli, Loredana Sarmati, Massimo Giuliani, Alessandra Latini, Evangelo Boumis, Mauro Zaccarelli, Rita Bellagamba, Massimo Andreoni, Anne-Geneviève Marcelin, Vincent Calvez, Andrea Antinori, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Maria Mercedes Santoro
Publié 2014